Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 3546 | 2018 |
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, L Richeldi, CC Thomson, Y Inoue, T Johkoh, ... American Journal of Respiratory and Critical Care Medicine 205 (9), e18-e47, 2022 | 1709 | 2022 |
European respiratory society, Japanese respiratory society, and latin American thoracic society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018 198 …, 2018 | 536* | 2018 |
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 465 | 2018 |
Methotrexate and rheumatoid arthritis associated interstitial lung disease PA Juge, JS Lee, J Lau, L Kawano-Dourado, JR Serrano, M Sebastiani, ... European Respiratory Journal 57 (2), 2021 | 225 | 2021 |
Hypersensitivity pneumonitis M Selman, I Buendía-Roldán, C Navarro, M Gaxiola Pulmonary Hypertension and Interstitial Lung Disease, 145-164, 2017 | 175 | 2017 |
American thoracic society, European respiratory society, Japanese respiratory society, and Latin American thoracic society. Diagnosis of idiopathic pulmonary fibrosis. An … G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... Am J Respir Crit Care Med 198 (5), e44-e68, 2018 | 100 | 2018 |
PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses M Bueno, D Zank, I Buendia-Roldán, K Fiedler, BG Mays, D Alvarez, ... PLoS One 14 (6), e0218003, 2019 | 87 | 2019 |
Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects C García de Alba, I Buendia-Roldán, A Salgado, C Becerril, R Ramírez, ... American journal of respiratory and critical care medicine 191 (4), 427-436, 2015 | 77 | 2015 |
Idiopathic pulmonary fibrosis: clinical behavior and aging associated comorbidities I Buendía-Roldán, M Mejía, C Navarro, M Selman Respiratory Medicine 129, 46-52, 2017 | 62 | 2017 |
Aging and pulmonary fibrosis M Selman, I Buendía-Roldán, A Pardo Revista de investigación clínica 68 (2), 75-83, 2016 | 61 | 2016 |
Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis T Groot Kormelink, A Pardo, K Knipping, I Buendía-Roldán, ... PLoS One 6 (9), e25392, 2011 | 58 | 2011 |
Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality Y Palacios, A Ruiz, LA Ramon-Luing, R Ocana-Guzman, ... International journal of molecular sciences 22 (16), 8423, 2021 | 56 | 2021 |
Increased expression of CC16 in patients with idiopathic pulmonary fibrosis I Buendía-Roldán, V Ruiz, P Sierra, E Montes, R Ramírez, A Vega, ... PLoS One 11 (12), e0168552, 2016 | 53 | 2016 |
Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis L Planas‐Cerezales, EG Arias‐Salgado, I Buendia‐Roldán, ... Respirology 24 (2), 146-153, 2019 | 49 | 2019 |
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19 I Fricke-Galindo, A Martínez-Morales, L Chávez-Galán, R Ocaña-Guzmán, ... Frontiers in Immunology 13, 949413, 2022 | 38 | 2022 |
Lower levels of α-Klotho in serum are associated with decreased lung function in individuals with interstitial lung abnormalities I Buendia-Roldan, N Machuca, M Mejía, M Maldonado, A Pardo, ... Scientific Reports 9 (1), 10801, 2019 | 37 | 2019 |
An open-label study with pirfenidone on chronic hypersensitivity pneumonitis H Mateos-Toledo, M Mejía-Ávila, Ó Rodríguez-Barreto, JG Mejía-Hurtado, ... Archivos de Bronconeumología 56 (3), 163-169, 2020 | 35 | 2020 |
Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection C Delgado, E Krötzsch, LA Jiménez-Alvarez, G Ramirez-Martinez, ... Lung 193, 25-30, 2015 | 35 | 2015 |
Hypersensitivity pneumonitis: diagnostic and therapeutic challenges ML Alberti, E Rincon-Alvarez, I Buendia-Roldan, M Selman Frontiers in Medicine 8, 718299, 2021 | 34 | 2021 |